Fig. 6From: Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE studyChange from baseline in loss of sense of smell VAS score by surgery number. CI Confidence interval, SC Subcutaneous, VAS visual analogue scaleBack to article page